Skip to main content

US ClosedU.S. Closed

BIOA: BioAge Labs Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

BioAge Labs, Inc. , a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases.

52W Range

24thpctl

Volume

0.63×avg

Market Cap

363.32MUSD

P/E Ratio

-4.1TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

BioAge Labs Inc.

BIOANASDAQ·USD·Closed

BioAge Labs Inc.

BIOANASDAQ·USD·Closed

$9.65

−4.27%

$9.65

−$0.43 (4.27%)

52W Range

24thpctl

Volume

0.63×avg

Mkt Cap

363.32MUSD

P/E

-4.1TTM

Div Yield

–ann